Role of colonic microbiota in colorectal carcinogenesis: A systematic review

Revista Espanola de Enfermedades Digestivas

Volumn 107, Issue 11, 2015, Pages 659-671

  Borges Canha, Marta ^a   Portela Cidade, José Pedro ^a   Dinis Ribeiro, Mário ^a,b   Leite Moreira, Adelino F ^a   Pimentel Nunes, Pedro ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Colon microbiota; Colorectal cancer; Innate immunity; Microbiome

Indexed keywords

AMINO ACID; APC PROTEIN; BACTERIAL TOXIN; BETA CATENIN; BUTYRIC ACID; CYCLOMODULIN; INTERLEUKIN 10; INTERLEUKIN 17; K RAS PROTEIN; PROTEIN BAX; PROTEIN P53; SMAD2 PROTEIN; SMAD4 PROTEIN; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACTINOBACTERIA; AKKERMANSIA; ALISTIPES; BACTERIAL METABOLISM; BACTERIUM; BACTEROIDETES; BIFIDOBACTERIUM; CARCINOGENESIS; COLON FLORA; COLORECTAL CANCER; CORIOBACTERIDAE; DYSBIOSIS; FAECALIBACTERIUM; FIRMICUTES; FUSOBACTERIA; GENE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTRACELLULAR SIGNALING; LACTOBACILLUS; METABOLITE; METHANOBACTERIALES; MISMATCH REPAIR; NONHUMAN; PORPHYROMONADACEAE; PROTEIN EXPRESSION; PROTEOBACTERIA; REVIEW; ROSEBURIA; RUMINOCOCCUS; STAPHYLOCOCCACEAE; SYSTEMATIC REVIEW; TREPONEMA; ANIMAL; COLON; COLORECTAL TUMOR; META ANALYSIS; MICROBIOLOGY; MICROFLORA;

ANIMALS; CARCINOGENESIS; COLON; COLORECTAL NEOPLASMS; DYSBIOSIS; HUMANS; MICROBIOTA;

EID: 84951126015     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.17235/reed.2015.3830/2015     Document Type: Review

References (50)

1. Candela M, Guidotti M, Fabbri A, et al. Human intestinal microbiota: Cross-talk with the host and its potential role in colorectal cancer. Crit Rev Microbiol 2011; 37: 1-14. DOI: 10.3109/1040841X.2010.501760
2. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-9. DOI: 10.1126/science.1124234
3. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature 2007; 449: 804-10. DOI: 10.1038/nature06244
4. Shen XJ, Rawls JF, Randall T, et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010; 1: 138-47. DOI: 10.4161/gmic.1.3.12360
5. Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011; 6: e16393. DOI: 10.1371/journal. pone.0016393
6. Rustgi AK. The genetics of hereditary colon cancer. Genes & development.2007; 21: 2525-38. DOI: 10.1101/gad.1593107
7. Watson AJ, Collins PD. Colon cancer: A civilization disorder. Dig Dis.2011; 29: 222-8. DOI: 10.1159/000323926
8. Riscuta G, Dumitrescu RG. Nutrigenomics: Implications for breast and colon cancer prevention. Methods Mol Biol 2012; 863: 343-58.
9. Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500: 541-6. DOI: 10.1038/nature12506
10. Vogelstein B, Papadopoulos N, Velculescu VE, et al. Cancer genome landscapes. Science 2013; 339: 1546-58. DOI: 10.1126/science.1235122
11. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600. DOI: 10.1016/0092-8674(81)90021-0
12. Medema JP, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011; 474: 318-26. DOI: 10.1038/nature10212
13. Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet 2010; 375: 1030-47. DOI: 10.1016/S0140-6736(10)60353-4
14. Poulogiannis G, Frayling IM, Arends MJ. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome. Histopathology 2010; 56: 167-79. DOI: 10.1111/j.1365-2559.2009.03392. x
15. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003; 21: 1174-9. DOI: 10.1200/JCO.2003.04.060
16. Pimentel-Nunes P, Goncalves N, Boal-Carvalho I, et al. Decreased Toll-interacting protein and peroxisome proliferator-activated receptor gamma are associated with increased expression of Toll-like receptors in colon carcinogenesis. Journal of Clinical Pathology 2012; 65: 302-8. DOI: 10.1136/jclinpath-2011-200567
17. Pimentel-Nunes P, Teixeira AL, Pereira C, et al. Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans. Digestive and Liver Disease 2013; 45: 63-9. DOI: 10.1016/j. dld.2012.08.006
18. Uronis JM, Muhlbauer M, Herfarth HH, et al. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One 2009; 4: e6026. DOI: 10.1371/journal. pone.0006026
19. Tyler AD, Smith MI, Silverberg MS. Analyzing the human microbiome: A "how to" guide for physicians. The American Journal of Gastroenterology.2014; 109: 983-93. DOI: 10.1038/ajg.2014.73
20. Fierer N, Bradford MA, Jackson RB. Toward an ecological classification of soil bacteria. Ecology 2007; 88: 1354-64. DOI: 10.1890/05-1839
21. Wang T, Cai G, Qiu Y, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. The ISME Journal 2012; 6: 320-9. DOI: 10.1038/ismej.2011.109
22. Wu N, Yang X, Zhang R, et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol 2013; 66: 462-70. DOI: 10.1007/s00248-013-0245-9
23. Zhu Q, Jin Z, Wu W, et al. Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One 2014; 9: e90849. DOI: 10.1371/journal. pone.0090849
24. Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumorimmune microenvironment. Cell Host Microbe 2013; 14: 207-15. DOI: 10.1016/j. chom.2013.07.007
25. McCoy AN, Araujo-Perez F, Azcarate-Peril A, et al. Fusobacterium is associated with colorectal adenomas. PLoS One 2013; 8: e53653. DOI: 10.1371/journal. pone.0053653
26. Mira-Pascual L, Cabrera-Rubio R, Ocon S, et al. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol 2014; 10.1007/s00535-014-0963-x. DOI: 10.1007/s00535-014-0963-x
27. Marchesi JR, Dutilh BE, Hall N, et al. Towards the human colorectal cancer microbiome. PLoS One 2011; 6(5): e20447. DOI: 10.1371/journal. pone.0020447
28. Zackular JP, Baxter NT, Iverson KD, et al. The gut microbiome modulates colon tumorigenesis. MBio 2013; 4: e00692-13. DOI: 10.1128/mBio.00692-13
29. Baxter NT, Zackular JP, Chen GY, et al. Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome 2014; 2: 20. DOI: 10.1186/2049-2618-2-20
30. Boleij A, Hechenbleikner EM, Goodwin AC, et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis 2015; 60: 208-15. DOI: 10.1093/cid/ciu787
31. Brim H, Yooseph S, Zoetendal EG, et al. Microbiome analysis of stool samples from African Americans with colon polyps. PLoS One 2013; 8: e81352. DOI: 10.1371/journal. pone.0081352
32. Gueimonde M, Ouwehand A, Huhtinen H, et al. Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol 2007; 13: 3985-9. DOI: 10.3748/wjg. v13. i29.3985
33. Scanlan PD, Shanahan F, Clune Y, et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environmental Microbiology 2008; 10: 789-98. DOI: 10.1111/j.1462-2920.2007.01503. x
34. Bonnet M, Buc E, Sauvanet P, et al. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res 2014; 20: 859-67. DOI: 10.1158/1078-0432. CCR-13-1343
35. Arthur JC, Gharaibeh RZ, Muhlbauer M, et al. Microbial genomic analysis reveals the essential role of inflammation in bacteriainduced colorectal cancer. Nat Commun 2014; 5: 4724. DOI: 10.1038/ncomms5724
36. Weir TL, Manter DK, Sheflin AM, et al. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 2013; 8: e70803. DOI: 10.1371/journal. pone.0070803
37. Singh N, Gurav A, Sivaprakasam S, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014; 40: 128-39. DOI: 10.1016/j. immuni.2013.12.007
38. Sato K, Tsuchihara K, Fujii S, et al. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res 2007; 67: 9677-84. DOI: 10.1158/0008-5472. CAN-07-1462
39. Buc E, Dubois D, Sauvanet P, et al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One 2013; 8: e56964. DOI: 10.1371/journal. pone.0056964
40. Zackular JP, Rogers MA, Ruffin MTt, et al. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila). Cancer Prev Res (Phila) 2014; 10.1158/1940-6207. capr-14-0129. DOI: 10.1158/1940-6207. CAPR-14-0129
41. Song X, Gao H, Lin Y, et al. Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis. Immunity 2014; 40: 140-52. DOI: 10.1016/j. immuni.2013.11.018
42. Dennis KL, Wang Y, Blatner NR, et al. Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. Cancer Res 2013; 73: 5905-13. DOI: 10.1158/0008-5472. CAN-13-1511
43. Klimesova K, Kverka M, Zakostelska Z, et al. Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice. Inflamm Bowel Dis 2013; 19: 1266-77. DOI: 10.1097/MIB.0b013e318281330a
44. Szigeti R, Pangas SA, Nagy-Szakal D, et al. SMAD4 haploinsufficiency associates with augmented colonic inflammation in select humans and mice. Ann Clin Lab Sci 2012; 42: 401-8.
45. Li Y, Kundu P, Seow SW, et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis 2012; 33: 1231-8. DOI: 10.1093/carcin/bgs137
46. Hu B, Elinav E, Huber S, et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc Natl Acad Sci U S A 2013; 110: 9862-7. DOI: 10.1073/pnas.1307575110
47. Irrazabal T, Belcheva A, Girardin SE, et al. The multifaceted role of the intestinal microbiota in colon cancer. Mol Cell 2014; 54: 309-20. DOI: 10.1016/j. molcel.2014.03.039
48. Turner ND, Ritchie LE, Bresalier RS, et al. The microbiome and colorectal neoplasia: Environmental modifiers of dysbiosis. Curr Gastroenterol Rep 2013; 15: 346. DOI: 10.1007/s11894-013-0346-0
49. Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe.2014; 15: 317-28. DOI: 10.1016/j. chom.2014.02.007
50. Hagland HR, Soreide K. Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways. Cancer Lett 2014 Mar 12; 10.1016/j. canlet.2014.02.026.